Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Evaluation and Monitoring of Patients With HIV Infectionn

Completed

Conditions: HIV

First Posted Date: 2007-11-14

Last Posted Date: 2017-07-02

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 600

Registration Number: NCT00557570

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Live Lung Donor Retrospective Study

Completed

Conditions: Lung Transplantation

First Posted Date: 2007-11-04

Last Posted Date: 2017-03-27

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 369

Registration Number: NCT00553397

Locations: 🇺🇸
University of Southern California, Los Angeles, California, United States
🇺🇸
Washington University Medical Center, St. Louis, Missouri, United States

Safety, Reactogenicity, and Immunogenicity of Inactivated Influenza A/H7/N7 Vaccine in Healthy Adults

Phase 1

Completed

Conditions: Influenza

Interventions: Biological: Influenza A/H7N7 Vaccine
Drug: Placebo

First Posted Date: 2007-10-19

Last Posted Date: 2013-08-23

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 126

Registration Number: NCT00546585

Locations: 🇺🇸
Baylor College of Medicine - Department of Molecular Virology and Microbiology, Houston, Texas, United States

Blood Levels of Tenofovir Gel in HIV Uninfected Pregnant Women Planning Cesarean Delivery

Phase 1

Completed

Conditions: HIV Infections

Interventions: Drug: Tenofovir 1% vaginal gel

First Posted Date: 2007-10-08

Last Posted Date: 2021-10-25

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 21

Registration Number: NCT00540605

Locations: 🇺🇸
Pitt CRS, Pittsburgh, Pennsylvania, United States

Optimizing Treatment for Treatment-Experienced, HIV-Infected People

Phase 3

Completed

Conditions: HIV Infections

Interventions: Drug: Enfuvirtide
Drug: Raltegravir
Drug: Darunavir
Drug: Tipranavir
Drug: Etravirine
Drug: Maraviroc

First Posted Date: 2007-10-01

Last Posted Date: 2021-11-04

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 517

Registration Number: NCT00537394

Locations: 🇺🇸
Children's National Med. Ctr. ATN CRS, Washington, District of Columbia, United States
🇺🇸
Univ. of Rochester ACTG CRS, Rochester, New York, United States
🇺🇸
UCLA CARE Center CRS, Los Angeles, California, United States

and more 61 locations

Safety of and Immune Response to a West Nile Virus Vaccine (WN/DEN4delta30) in Healthy Adults

Phase 1

Completed

Conditions: West Nile Fever

Interventions: Biological: WN/DEN4delta30 vaccine
Biological: Placebo

First Posted Date: 2007-09-28

Last Posted Date: 2013-01-03

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 26

Registration Number: NCT00537147

Locations: 🇺🇸
Center for Immunization Research, Johns Hopkins School of Public Health (MD Location), Baltimore, Maryland, United States
🇺🇸
Center for Immunization Research, Johns Hopkins School of Public Health (DC Location), Washington, District of Columbia, United States

Influenza in People With Normal and Weakened Immune Systems

Completed

Conditions: Viral Infections
Respiratory Infections

First Posted Date: 2007-09-21

Last Posted Date: 2022-11-10

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 137

Registration Number: NCT00533182

Locations: 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States

SARS Coronavirus Vaccine (SARS-CoV)

Phase 1

Withdrawn

Conditions: Coronavirus (SARS-CoV)

Interventions: Drug: Placebo
Drug: Aluminum hydroxide
Biological: SARS-CoV

First Posted Date: 2007-09-21

Last Posted Date: 2012-12-03

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Registration Number: NCT00533741

Locations: 🇺🇸
Baylor College of Medicine - Molecular Virology and Microbiology, Houston, Texas, United States

Effects of Donor and Recipient Genetic Expression on Heart, Lung, Liver, or Kidney Transplant Survival

Completed

Conditions: Heart Transplantation
Liver Transplantation
Lung Transplantation
Kidney Transplantation

First Posted Date: 2007-09-19

Last Posted Date: 2013-06-04

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 313

Registration Number: NCT00531921

Locations: 🇺🇸
University of Pennsylvania (heart, kidney, liver, lung), Philadelphia, Pennsylvania, United States
🇺🇸
Columbia University (lung and liver), New York, New York, United States
🇺🇸
Cornell University Medical College (kidney), Ithaca, New York, United States

and more 2 locations

Safety and Effectiveness of PENNVAX-B Vaccine Alone, With Il-12, or IL-15 in Healthy Adults

Phase 1

Completed

Conditions: HIV Infections

Interventions: Biological: PennVax B
Biological: IL-15
Biological: IL-12

First Posted Date: 2007-09-12

Last Posted Date: 2021-10-14

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 120

Registration Number: NCT00528489

Locations: 🇺🇸
Alabama Vaccine CRS, Birmingham, Alabama, United States
🇺🇸
Brigham and Women's Hosp. CRS, Boston, Massachusetts, United States
🇺🇸
NY Blood Ctr./Bronx CRS, Bronx, New York, United States

and more 5 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy